Impingement Syndrome Market Research Report - Global Forecast Till 2023

Impingement Syndrome Market Information: By Types (Structural Impingement, Functional Impingement), By Diagnosis (Physical Examination, Imaging), By Treatment (Drug Treatment, Non-Pharmacological Treatment, Surgery), By End Users (Hospitals, Physical Therapists) - Global Forecast Till 2023

ID: MRFR/Pharma/2968-HCR | February 2021 | Region: Global | 110 pages

Market Scenario
Impingement syndrome or subacromial impingement occurs when the tendons of the rotator cuff muscles become impinged and inflamed as they pass through the subacromial space. There are two major types of this disease, structural impingement and functional impingement. Different types of diagnosis methods like bone spurs, rotator cuff injury, labral injury, shoulder instability, biceps tendinopathy and scapula dysfunction can be used to diagnose this disorder. Increasing prevalence of orthopedic diseases, rising geriatric population and changing lifestyle have boosted the growth of the market. According to International Osteoporosis Foundation, worldwide osteoporosis causes more than 8.9 million fractures annually. Moreover, increasing healthcare expenditure and government initiatives for research and development have fuelled the market growth. However, high cost surgeries, and lack of awareness about this disorder may slow the growth of the market.
The global impingement syndrome market is expected to grow at a CAGR of ~6.8% during the forecast period 2017-2023.

Research Methodology

Source: World Health Organization, Centers for Disease Control and Prevention, expert interview market research future analysis, annual report, white paper, company presentation

Segmentation          
The global impingement syndrome market is segmented on the basis of types, diagnosis, treatment, and end users. On the basis of types, the market is segmented into structural impingement, and functional impingement.
On the basis of diagnosis, the market is segmented into physical examination, imaging, and other. Imaging is further segmented into ultrasonography, arthrography and MRI.
On the basis of treatment, the market is categorized into drug treatment, non-pharmacological treatment, and surgery. Drug treatment is further segmented into corticosteroid, local anesthetic, NSAIDs, and other. Non-pharmacological treatment is further segmented into joint mobilization, interferential therapy, acupuncture, soft tissue therapy, therapeutic taping, rotator cuff strengthening, and other. Surgery segment is subsegmented into arthroscopic surgery, open surgery and others.
On the basis of end user, the market is segmented into hospitals, physical therapists, and others.
Key Players    
        
Some of the key players in this market are ATOS Klinik Heidelberg GmbH & Co. KG (Germany), DePuy Synthes (US), Johnson & Johnson Services, Inc. (US), Stryker Corporation (US), Medtronic (Ireland), Smith & Nephew (UK), B. Braun Melsungen AG (Germany), Abbott (US), Immediate Media Company Ltd. (US)
Figure: Global Impingement Syndrome Market, by Treatment, 2016 (%)

Source: World Health Organization, Centers for Disease Control and Prevention, expert interview market research future analysis, annual report, white paper, company presentation
 Regional Analysis

The America dominates the global impingement syndrome market owing to the presence of huge geriatric population, increasing number of patient suffering from orthopedic diseases and increasing healthcare expenditure. Moreover, high healthcare speeding is another major factor contributing to the market growth.
Europe accounts for the second largest impingement syndrome market across the globe owing to increasing government support for research & development, increasing investment in healthcare, and well developed healthcare sector.
Asia Pacific has the fastest growing market, increasing government support for research & development, increasing prevalence of chronic diseases, huge population base and rapidly developing economy drives the growth of the market in this region.  
The Middle East & Africa is expected to show a least market share due to less availability of medical facilities, and less development in healthcare domain.
Intended Audience

Pharmaceutical Companies
Medical Devices Manufacturer
Research and Development (R&D) Companies
Market Research and Consulting Service Providers
Potential Investors



Frequently Asked Questions (FAQ) :


Global impingement syndrome market is projected to grow at approximately 5.3% CAGR during the assessment period (2017-2023).

Increasing healthcare expenditure and government initiatives for R&D, are major tailwinds pushing the growth of the global impingement syndrome market.

High cost surgeries and lack of awareness about this disorder are major growth impeders for the global impingement syndrome market.

North America holds the largest share in the global impingement syndrome market, followed by Europe and the Asia Pacific, respectively.

ATOS Klinik Heidelberg GmbH & Co. KG (Germany), Johnson & Johnson Services, Inc. (US), DePuy Synthes (US), Stryker Corporation (US), Smith & Nephew (UK), Medtronic (Ireland), B. Braun Melsungen AG (Germany), Immediate Media Company Ltd. (US), and Abbott (US), are some of the top players operating in the global impingement syndrome market.

Table of Contents
1 Report Prologue
2 Introduction

2.1 Definition

2.2 Scope of Study:

2.3 Research Objective

2.4 Market Structure
3 Research Process

3.1 Primary Research

3.2 Secondary Research
4 Market Dynamics

4.1 Introduction

4.2 Drivers

4.3 Restraints

4.4 Opportunities

4.5 Macroeconomic Indicators
5. Market Factor Analysis

5.1 Porters five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain

5.3 Investment Feasibility Analysis

5.4 Price Factor Analysis
6 Global Impingement Syndrome Market, by Type

6.1 Introduction

6.2 Structural Impingement

6.3 Functional Impingement
7 Global Impingement Syndrome Market, By Diagnosis

7.1 Physical Examination

7.2 Imaging

7.2.1 Ultrasonography

7.2.2 Arthrography

7.2.3 MRI
8 Global Impingement Syndrome Market, By Treatment

8.1 Introduction

8.2 Drug Treatment

8.2.1 Corticosteroid

8.2.2 Local Anesthetic

8.2.3 NSAIDs

8.2.4 Other

8.3 Non-Pharmacological Treatment

8.3.1 Joint Mobilization

8.3.2 Interferential Therapy

8.3.3 Acupuncture

8.3.4 Soft Tissue Therapy

8.3.5 Therapeutic Taping

8.3.6 Rotator Cuff Strengthening

8.3.7 Other

8.4 Surgery

8.4.1 Arthroscopic Surgery

8.4.2 Open Surgery

8.4.3 Others
9 Global Impingement Syndrome Market, by End User

9.1 Introduction

9.2 Hospitals,

9.3 Physical Therapists

9.4 Others
10 Global Impingement syndrome Market by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 U.S.

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 UK

10.3.1.4 Italy

10.3.1.5 Spain

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Republic Of Korea

10.4.5 Australia

10.4.6 Rest of Asia Pacific

10.5 Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest of Middle East & Africa
11 Competitive Landscape

11.1 Introduction

11.2 Market share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

12 Company Profile

12.1 ATOS Klinik Heidelberg GmbH & Co. KG.

12.1.1Overview

12.1.2Product/Business Segment Overview

12.1.3Financial Overview

12.1.4Key Development

12.2 DePuy Synthes

12.2.1Overview

12.2.2Product/Business Segment Overview

12.2.3Financial Overview

12.2.4Key Developments

12.3 Johnson & Johnson Services, Inc.

12.3.1Overview

12.3.2Product/Business Segment Overview

12.3.3Financial Overview

12.3.4Key Developments

12.4 Stryker Corporation

12.4.1Overview

12.4.2Product/Business Segment Overview

12.4.3Financial Overview

12.4.4Key Developments

12.5 Medtronic

12.5.1Overview

12.5.2Product/Business Segment Overview

12.5.3Financials Updates

12.5.4Key Developments

12.6 Smith & Nephew

12.6.1Overview

12.6.2Product/Business Segment Overview

12.6.3Financial Updates

12.6.4Key Developments

12.7 B. Braun Melsungen AG

12.7.1Overview

12.7.2Product/Business Segment Overview

12.7.3Financial Updates

12.7.4Key Developments

12.8 Abbott

12.8.1Overview

12.8.2Product/Business Segment Overview

12.8.3Financial Updates

12.8.4Key Developments

12.9 Immediate Media Company Ltd.

12.9.1Overview

12.9.2Product/Business Segment Overview

12.9.3Financial Updates

12.9.4Key Developments
13 MRFR Conclusion

13.1 Key Findings

13.1.1From CEO’s View Point

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Prediction of Tissue Engineering Industries
14 Appendix


List of Tables
TABLE 1 GLOBAL IMPINGEMENT SYNDROME MARKET, BY TYPE, 2017-2023 (USD MILLION)

TABLE 2 STRUCTURAL IMPINGEMENT FOR IMPINGEMENT SYNDROME MARKET, BY REGION, 2017-2023 (USD MILLION)

TABLE 3 FUNCTIONAL IMPINGEMENT FOR IMPINGEMENT SYNDROME MARKET, BY REGION 2017-2023 (USD MILLION)

TABLE 4 GLOBAL IMPINGEMENT SYNDROME MARKET, BY DAIGNOSIS, 2017-2023 (USD MILLION) TABLE

TABLE 5 GLOBAL IMPINGEMENT SYNDROME MARKET, BY TREATMENT, 2017-2023 (USD MILLION)

TABLE 6 GLOBAL IMPINGEMENT SYNDROME MARKET, BY END USER, 2017-2023 (USD MILLION)

TABLE 7 GLOBAL IMPINGEMENT SYNDROME MARKET, BY REGION 2017-2023 (USD MILLION)

TABLE 8 NORTH AMERICA IMPINGEMENT SYNDROME MARKET, BY COUNTRY 2017-2023 (USD MILLION)

TABLE 9 NORTH AMERICA IMPINGEMENT SYNDROME MARKET, BY TYPE 2017-2023 (USD MILLION)

TABLE 10 NORTH AMERICA IMPINGEMENT SYNDROME MARKET, BY DAIGNOSIS, 2017-2023 (USD MILLION) TABLE

TABLE 11 NORTH AMERICA IMPINGEMENT SYNDROME MARKET, BY TREATMENT, 2017-2023 (USD MILLION)

TABLE 12 NORTH AMERICA IMPINGEMENT SYNDROME MARKET, BY END USER, 2017-2023 (USD MILLION)

TABLE 13 NORTH AMERICA IMPINGEMENT SYNDROME MARKET BY REGION 2017-2023 (USD MILLION

TABLE 14 EUROPE IMPINGEMENT SYNDROME MARKET BY COUNTRY 2017-2023 (USD MILLION)

TABLE 15 EUROPE IMPINGEMENT SYNDROME MARKET, BY TYPE 2017-2023 (USD MILLION)

TABLE 16 EUROPE IMPINGEMENT SYNDROME MARKET, BY DAIGNOSIS, 2017-2023 (USD MILLION) TABLE

TABLE 17 EUROPE IMPINGEMENT SYNDROME MARKET, BY TREATMENT, 2017-2023 (USD MILLION)

TABLE 18 EUROPE IMPINGEMENT SYNDROME MARKET, BY END USER, 2017-2023 (USD MILLION)

TABLE 19 EUROPE IMPINGEMENT SYNDROME MARKET, BY REGION 2017-2023 (USD MILLION)

TABLE 20 ASIA PACIFIC IMPINGEMENT SYNDROME MARKET, BY COUNTRY 2017-2023 (USD MILLION)

TABLE 21 ASIA PACIFIC IMPINGEMENT SYNDROME MARKET, BY TYPE 2017-2023 (USD MILLION)

TABLE 22 ASIA PACIFIC IMPINGEMENT SYNDROME MARKET, BY DAIGNOSIS, 2017-2023 (USD MILLION) TABLE

TABLE 23 ASIA PACIFIC IMPINGEMENT SYNDROME MARKET, BY TREATMENT, 2017-2023 (USD MILLION)

TABLE 24 ASIA PACIFIC IMPINGEMENT SYNDROME MARKET, BY END USER, 2017-2023 (USD MILLION)

TABLE 25 ASIA PACIFIC IMPINGEMENT SYNDROME MARKET, BY REGION 2017-2023 (USD MILLION)

TABLE 26 MIDDLE EAST & AFRICA IMPINGEMENT SYNDROME MARKET, BY REGION 2017-2023 (USD MILLION)

TABLE 27 MIDDLE EAST & AFRICA IMPINGEMENT SYNDROME MARKET, BY TYPE 2017-2023 (USD MILLION)

TABLE 28 MIDDLE EAST & AFRICA IMPINGEMENT SYNDROME MARKET, BY DAIGNOSIS, 2017-2023 (USD MILLION) TABLE

TABLE 29 MIDDLE EAST & AFRICA IMPINGEMENT SYNDROME MARKET, BY TREATMENT, 2017-2023 (USD MILLION)

TABLE 30 MIDDLE EAST & AFRICA IMPINGEMENT SYNDROME MARKET, BY END USER, 2017-2023 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA IMPINGEMENT SYNDROME MARKET, BY REGION 2017-2023 (USD MILLION)


List of Figures
FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET DYNAMICS FOR GLOBAL IMPINGEMENT SYNDROME MARKET

FIGURE 3 ATTRITION RATE OF PHASE III CLINICAL TRIALS IN EUROPE, 2012

FIGURE 4 IMPINGEMENT SYNDROME SUCCESS RATES IN VARIOUS PHASES OF CLINICAL TRIALS

FIGURE 5 GLOBAL IMPINGEMENT SYNDROME MARKET SHARE, BY TYPE 2016

FIGURE 6 GLOBAL IMPINGEMENT SYNDROME MARKET SHARE, BY DAIGNOSIS, 2016

FIGURE 7 GLOBAL IMPINGEMENT SYNDROME MARKET SHARE, BY TREATMENT, 2016

FIGURE 8 GLOBAL IMPINGEMENT SYNDROME MARKET SHARE, BY END USER, 2016

FIGURE 9 GLOBAL IMPINGEMENT SYNDROME MARKET SHARE, BY REGION, 2016

FIGURE 10 NORTH AMERICA IMPINGEMENT SYNDROME MARKET SHARE, BY COUNTRY, 2016

FIGURE 11 EUROPE IMPINGEMENT SYNDROME MARKET SHARE, BY COUNTRY, 2016

FIGURE 12 ASIA PACIFIC IMPINGEMENT SYNDROME MARKET SHARE, BY COUNTRY, 2016

FIGURE 13 MIDDLE EAST & AFRICA IMPINGEMENT SYNDROME MARKET, BY REGION, 2016

FIGURE 14 GLOBAL IMPINGEMENT SYNDROME MARKET: COMPANY SHARE ANALYSIS, 2016 (%)

FIGURE 15 ATOS KLINIK HEIDELBERG GMBH & CO. KG.: KEY FINANCIALS

FIGURE 16 ATOS KLINIK HEIDELBERG GMBH & CO. KG.: SEGMENTAL REVENUE

FIGURE 17 ATOS KLINIK HEIDELBERG GMBH & CO. KG.: GEOGRAPHICAL REVENUE

FIGURE 18 DEPUY SYNTHES. KEY FINANCIALS

FIGURE 19 DEPUY SYNTHES. SEGMENTAL REVENUE

FIGURE 20 DEPUY SYNTHES: GEOGRAPHICAL REVENUE

FIGURE 21 JOHNSON & JOHNSON SERVICES, INC.: KEY FINANCIALS

FIGURE 22 JOHNSON & JOHNSON SERVICES, INC.: SEGMENTAL REVENUE

FIGURE 23 JOHNSON & JOHNSON SERVICES, INC.: GEOGRAPHICAL REVENUE

FIGURE 24 STRYKER CORPORATION. KEY FINANCIALS

FIGURE 25 STRYKER CORPORATION. SEGMENTAL REVENUE

FIGURE 26 STRYKER CORPORATION: GEOGRAPHICAL REVENUE

FIGURE 27 MEDTRONIC: FINANCIAL REVENUE

FIGURE 28 MEDTRONIC: SEGMENTAL REVENUE

FIGURE 29 MEDTRONIC: GEOGRPAHICAL REVENUE

FIGURE 30 SMITH & NEPHEW: FINANCIAL REVENUE

FIGURE 31 SMITH & NEPHEW: SEGMENTAL REVENUE

FIGURE 32 SMITH & NEPHEW: GEOGRPAHICAL REVENUE

FIGURE 33 B. BRAUN MELSUNGEN AG: FINANCIAL REVENUE

FIGURE 34 B. BRAUN MELSUNGEN AG: SEGMENTAL REVENUE

FIGURE 35 B. BRAUN MELSUNGEN AG: GEOGRPAHICAL REVENUE

FIGURE 36 ABBOTT: FINANCIAL REVENUE

FIGURE 37 ABBOTT: SEGMENTAL REVENUE

FIGURE 38 ABBOTT: GEOGRPAHICAL REVENUE